Rania El-Botty
6PUBLICATIONS
72CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Nov 07, 2025
ESR1-Activating Mutations Confer Metabolic Vulnerabilities in ER+ Breast Cancer.Francesca Bonechi, Marina Bacci, Nicla Lorito
|Feb 11, 2025
Acetalax and Bisacodyl for the Treatment of Triple-Negative Breast Cancer: A Combined Molecular and Preclinical Study.William C Reinhold, Elisabetta Marangoni, Fathi Elloumi
|Feb 28, 2024
Acetyl-CoA carboxylase 1 controls a lipid droplet-peroxisome axis and is a vulnerability of endocrine-resistant ER<sup>+</sup> breast cancer.Marina Bacci, Nicla Lorito, Alfredo Smiriglia
|Oct 06, 2023
Targeting Transcriptional Regulation with a CDK9 Inhibitor Suppresses Growth of Endocrine- and Palbociclib-Resistant ER+ Breast Cancers.Arany Soosainathan, Marjan Iravani, Rania El-Botty
|Jul 14, 2023
Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers.Rania El-Botty, Ludivine Morriset, Elodie Montaudon
|Feb 21, 2020
BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers.Florence Coussy, Rania El-Botty, Sophie Château-Joubert
Pageof 1
Frequent Collaborators
6 joint publications
Elisabetta Marangoni
3 joint publications
Marina Bacci
3 joint publications
Andrea Morandi
2 joint publications
Nicla Lorito
2 joint publications
Alfredo Smiriglia
2 joint publications
Ludivine Morriset
2 joint publications
Thibaut Larcher
2 joint publications
Laura Sourd
2 joint publications
Yves Pommier
2 joint publications
Icro Meattini
